NewcelX Ltd. Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-29: Form 20-F; Period of report 2025-12-31; Description ANNUAL REPORT; Document ea0287509-20f_newcelx.htm.
- 2025-05-16: Form 20-F; Period of report 2024-12-31; Description ANNUAL REPORT; Document ea0241513-20f_nlspharma.htm.
- 2024-05-15: Form 20-F; Period of report 2023-12-31; Description ANNUAL REPORT; Document ea0205871-20f_nlspharma.htm.
- 2023-05-05: Form 20-F; Period of report 2022-12-31; Description ANNUAL REPORT; Document f20f2022_nlspharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-29 | 20-F | 2025-12-31 | ANNUAL REPORT | ea0287509-20f_newcelx.htm |
| 2025-05-16 | 20-F | 2024-12-31 | ANNUAL REPORT | ea0241513-20f_nlspharma.htm |
| 2024-05-15 | 20-F | 2023-12-31 | ANNUAL REPORT | ea0205871-20f_nlspharma.htm |
| 2023-05-05 | 20-F | 2022-12-31 | ANNUAL REPORT | f20f2022_nlspharma.htm |
| 2022-03-24 | 20-F | 2021-12-31 | ANNUAL REPORT | f20f2021_nlspharma.htm |
| 2021-05-14 | 20-F | 2020-12-31 | ANNUAL REPORT | f20f2020_nlspharmaceutics.htm |